TABLE 3.
Results of MIF assay for detection of anti-C. pneumoniae IgG in serum specimens of CHD patients and healthy controls
| MIF IgG titer | No. (%) of subjects
|
|||
|---|---|---|---|---|
| Control (n = 100) | CHD (n = 219)a | UA (n = 179) | AMI (n = 40) | |
| ≤32 | 70 (70) | 70 (32)* | 56 (31) | 14 (35) |
| 32 | 23 (23) | 24 (11)* | 20 (11) | 4 (10) |
| 64 | 7 (7) | 22 (10) | 18 (10) | 4 (10) |
| 128 | 0 (0) | 42 (19)* | 36 (20) | 6 (15) |
| 256 | 0 (0) | 30 (14)* | 23 (13) | 7 (17) |
| ≥512 | 0 (0) | 31 (14)* | 26 (15) | 5 (13) |
a
*, statistically significant difference (P < 0.05 by two-tailed χ2 test) between CHD patients (pooled or individual UA and AMI data) and controls.